GSK

Gsk (GSK)

Buy
Sell
Company name:Gsk Plc
Company Description:A group engaged in the creation; discovery; development; manufacture and marketing of pharmaceutical and consumer health-related products
EPIC:GSKTrading Currency:GBX
Market Sector:FE10ISIN:GB00BN7SWP63
Market Segment:SET1Share Type:DE
WWW Address:http://www.gsk.com/Description:ORD 31 1/4P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 1,415.40 images.advfn.com/imagesnew/2/gb/down -9.6 [-0.67] 1,406.80 1,407.40 1,404.20 1,417.20 1,392.40 13,179,405
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 57,569.32 4,067.35 0.08 87.60 80.00 16.16 5.65 2,280.50 - 1,371.00

Gsk Key Figures

Key Figures
(at previous day's close)
Market Cap.57,569.32m
Shares In Issue4,067.35m
Prev. Close1,425.00
PE Ratio16.16 
Dividend Yield5.65%
EPS - basic87.60p
Dividend PS80.00p
Dividend Cover1.10 
Cash Flow PS195.51p
Return On Equity (ROE)29.13%
Operating Margin15.95%
PEG Factor-0.67 
EPS Growth Rate-24.16%
Dividends PS Growth Rate-%
Net Debt53,487.00m
Gross Gearing73.02%
Quick Assets17,860.00m
Net Working Capital-27.00m
Intangibles / Fixed Assets73.26%
Turnover PS838.73p
Pre-Tax Profit PS133.80p
Retained Profit PS9.49p
Cash PS105.08p
Net Cash PS-476.87p
Net Tangible Asset Value PS *-628.81p
Net Asset Value PS524.71p
Spread0.60 (0.04%) 

Gsk Balance Sheet

%1$s Balance Sheet
L^GSK:Liabilities+EQL^GSK:Assets

Share Price Performance

Share Price Performance
Sample Period HighLow
1 week1,652.001,371.00
4 weeks1,808.401,371.00
12 weeks2,280.501,371.00
1 year2,280.501,371.00

Share Price Chart (5 years)

Share Price Chart (5 years)

Gsk Historic Returns

%1$s Historic Returns
Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week1,649.40-234.00-14.191,371.0017.541,442.12
4 weeks1,798.20-382.80-21.291,371.0011.291,610.63
12 weeks2,235.75-820.35-36.691,371.0011.801,965.35
26 weeks1,970.25-554.85-28.161,371.0011.262,032.73
1 year1,866.00-450.60-24.151,371.009.631,985.55
3 years2,071.75-656.35-31.681,371.009.351,924.69
5 years1,878.75-463.35-24.661,371.009.241,896.37

Gsk Key Management Ratios

DEEPER ANALYSIS

Gsk Investment Ratios

%1$s Investment Ratios
(Market value analysis) at previous day's close
PQ Ratio22.61 
PE Ratio16.16 
Tobin's Q Ratio 0.72 
Tobin's Q Ratio (excl. intangibles)1.47 
Dividend Yield5.65%
Market-to-Book Ratio3.82 
Price-to-Pre-Tax Profit PS10.58 
Price-to-Retained Profit PS149.14 
Price-to-Cash Flow PS7.24 
Price-to-Sales PS1.69 
Price-to-Net Tangible Asset Value PS-2.98 
Price-to-Cash PS13.47 
Net Working Capital PS-0.66 
Price Pct to Working Capital PS-2,132.24%
Earnings Yield6.19%
Average PE27.81 
Years in average5 
PE to PE average58.09%

Gsk Financial Ratios

%1$s Financial Ratios
(Leverage Ratios)
Debt Ratio61.50%
Debt-to-Equity Ratio1.60 
Debt-to-Equity Ratio (excl. Intgbl)-1.77 
Debt-to-Equity Market Value0.59 
Net Gearing67.62%
Net Gearing (excl. Intangibles)139.03%
Gross Gearing73.02%
Gross Gearing (excl. Intangibles)150.14%
Gearing Under 1 Year29.92%
Gearing Under 1 Year (excl. Intgbl)61.53%
Assets/Equity3.71 
Cash/Equity20.03 
(Liquidity Ratios)
Net Working Capital to Total Assets-0.03%
Current Ratio1.00 
Quick Ratio (Acid Test)0.75 
Liquidity Ratio0.18 
Cash & Equiv/Current Assets18.08%
(Solvency Ratios)
Enterprise Value93,673.32m
CFO/Sales0.23 
CFO/Attributable Profit1.81 
CFO/Assets0.10 
CFO/Debt0.14 
Total Debt/Equity Market Value1.00 
Total Debt/Sales1.69 
Total Debt/Pre-Tax Profit10.61 
Total Debt57,761.00m
Total Debt/Net Current Assets-2,139.34%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth22.78%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs10 
Beta coefficients
Beta (60-Mnth)Beta (36-Mnth)
0.07510.1286

Gsk Operating Ratios

%1$s Operating Ratios
(Profitability Ratios)
Return On Capital Employed (ROCE)9.82%
Return On Assets (ROA)5.50%
Net Profit Margin12.85%
Assets Turnover0.43 
Return On Equity (ROE)29.13%
Return On Investment (ROI)7.71%
Dividend Payout Ratio91.32%
Plowback Ratio8.68%
Growth from Plowback Ratio2.57%
Net Income Of Revenues1.13%
(Asset Utilisation Multiples)
Shareholders Equity Turnover2.30 
Fixed Assets Turnover0.61 
Current Assets Turnover1.42 
Net Working Capital Turnover 
Inventory Turnover5.79 
(Other Operating Ratios)
Total Assets-to-Sales2.34 
Debtors-to-Sales37.34%
Debt Collection Period136.28Days

Gsk Dividends

%1$s Dividends
Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
27 Jul 2022QuarterlyGBX16.2531/12/202131/12/202218/08/202219/08/202206/10/2022-
27 Apr 2022QuarterlyGBX14.0031/12/202131/12/202219/05/202220/05/202201/07/2022-
09 Feb 2022FinalGBX23.0031/12/202031/12/202124/02/202225/02/202207/04/202280.00
27 Oct 2021QuarterlyGBX19.0031/12/202031/12/202118/11/202119/11/202113/01/2022-
28 Jul 2021QuarterlyGBX19.0031/12/202031/12/202119/08/202120/08/202107/10/2021-
28 Apr 2021QuarterlyGBX19.0031/12/202031/12/202120/05/202121/05/202108/07/2021-
03 Feb 2021FinalGBX23.0031/12/201931/12/202018/02/202119/02/202108/04/202180.00
28 Oct 2020QuarterlyGBX19.0031/12/201931/12/202012/11/202013/11/202014/01/2021-
29 Jul 2020QuarterlyGBX19.0031/12/201931/12/202013/08/202014/08/202008/10/2020-
29 Apr 2020QuarterlyGBX19.0031/12/201931/12/202014/05/202015/05/202009/07/2020-
05 Feb 2020FinalGBX23.0031/12/201831/12/201920/02/202021/02/202009/04/202080.00
30 Oct 2019QuarterlyGBX19.0031/12/201831/12/201914/11/201915/11/201909/01/2020-
24 Jul 2019QuarterlyGBX19.0031/12/201831/12/201908/08/201909/08/201910/10/2019-
01 May 2019QuarterlyGBX19.0031/12/201831/12/201916/05/201917/05/201911/07/2019-
06 Feb 2019FinalGBX23.0031/12/201731/12/201821/02/201922/02/201911/04/201980.00
31 Oct 2018QuarterlyGBX19.0031/12/201731/12/201815/11/201816/11/201810/01/2019-
25 Jul 2018QuarterlyGBX19.0031/12/201731/12/201809/08/201810/08/201811/10/2018-
25 Apr 2018QuarterlyGBX19.0031/12/201731/12/201810/05/201811/05/201812/07/2018-
07 Feb 2018FinalGBX23.0031/12/201631/12/201722/02/201823/02/201812/04/201880.00
25 Oct 2017QuarterlyGBX19.0031/12/201631/12/201709/11/201710/11/201711/01/2018-
26 Jul 2017QuarterlyGBX19.0031/12/201631/12/201710/08/201711/08/201712/10/2017-
26 Apr 2017QuarterlyGBX19.0031/12/201631/12/201711/05/201712/05/201713/07/2017-
08 Feb 2017FinalGBX23.0031/12/201531/12/201623/02/201724/02/201713/04/201780.00
26 Oct 2016QuarterlyGBX19.0031/12/201531/12/201603/11/201604/11/201612/01/2017-
27 Jul 2016QuarterlyGBX19.0031/12/201531/12/201611/08/201612/08/201613/10/2016-
27 Apr 2016QuarterlyGBX19.0031/12/201531/12/201612/05/201613/05/201614/07/2016-
03 Feb 2016SpecialGBX20.0031/12/201431/12/201518/02/201619/02/201614/04/2016-
03 Feb 2016FinalGBX23.0031/12/201431/12/201518/02/201619/02/201614/04/2016100.00
19 Oct 2015QuarterlyGBX19.0031/12/201431/12/201512/11/201513/11/201514/01/2016-
29 Jul 2015QuarterlyGBX19.0031/12/201431/12/201513/08/201514/08/201501/10/2015-
06 May 2015QuarterlyGBX19.0031/12/201431/12/201514/05/201515/05/201509/07/2015-
04 Feb 2015FinalGBX23.0031/12/201331/12/201419/02/201520/02/201509/04/201580.00
22 Oct 2014QuarterlyGBX19.0031/12/201331/12/201406/11/201407/11/201408/01/2015-
24 Jul 2014QuarterlyGBX19.0031/12/201331/12/201406/08/201408/08/201402/10/2014-
30 Apr 2014QuarterlyGBX19.0031/12/201331/12/201414/05/201416/05/201410/07/2014-
05 Feb 2014FinalGBX23.0031/12/201231/12/201319/02/201421/02/201410/04/201478.00
23 Oct 2013QuarterlyGBX19.0031/12/201231/12/201313/11/201315/11/201309/01/2014-
24 Jul 2013QuarterlyGBX18.0031/12/201231/12/201307/08/201309/08/201303/10/2013-
24 Apr 2013QuarterlyGBX18.0031/12/201231/12/201308/05/201310/05/201311/07/2013-
06 Feb 2013FinalGBX22.0031/12/201131/12/201220/02/201322/02/201311/04/201374.00
31 Oct 2012QuarterlyGBX18.0031/12/201131/12/201214/11/201216/11/201203/01/2013-
25 Jul 2012QuarterlyGBX17.0031/12/201131/12/201208/08/201210/08/201204/10/2012-
25 Apr 2012QuarterlyGBX17.0031/12/201131/12/201209/05/201211/05/201205/07/2012-
07 Feb 2012FinalGBX21.0031/12/201031/12/201115/02/201217/02/201212/04/201275.00
07 Feb 2012SpecialGBX5.0031/12/201031/12/201115/02/201217/02/201212/04/2012-
26 Oct 2011InterimGBX17.0031/12/201031/12/201102/11/201104/11/201105/01/2012-
26 Jul 2011InterimGBX16.0031/12/201031/12/201103/08/201105/08/201106/10/2011-
27 Apr 2011InterimGBX16.0031/12/201031/12/201104/05/201106/05/201107/07/2011-
03 Feb 2011FinalGBX19.0031/12/200931/12/201009/02/201111/02/201107/04/201165.00
21 Oct 2010InterimGBX16.0031/12/200931/12/201027/10/201029/10/201006/01/2011-
21 Jul 2010InterimGBX15.0031/12/200931/12/201028/07/201030/07/201007/10/2010-
28 Apr 2010InterimGBX15.0031/12/200931/12/201005/05/201007/05/201008/07/2010-
04 Feb 2010FinalGBX18.0031/12/200831/12/200910/02/201012/02/201008/04/201061.00
29 Oct 2009QuarterlyGBX15.0031/12/200831/12/200904/11/200906/09/200907/01/2010-
30 Jul 2009QuarterlyGBX14.0031/12/200831/12/200931/07/200931/07/200908/10/200928.00
22 Apr 2009QuarterlyGBX14.0031/12/200831/12/200929/04/200901/05/200909/07/2009-
05 Feb 2009FinalGBX17.0031/12/200731/12/200811/02/200913/02/200909/04/200957.00
22 Oct 2008QuarterlyGBX14.0031/12/200731/12/200829/10/200831/10/200809/01/2008-
07 Feb 2008FinalGBX13.0031/12/200631/12/200713/02/200815/02/200810/04/200853.00
25 Jul 2007QuarterlyGBX12.0031/12/200631/12/200701/08/200703/08/200711/10/2007-
24 Apr 2007QuarterlyGBX12.0031/12/200631/12/200702/05/200704/05/200712/07/2007-
08 Feb 2007QuarterlyGBX14.0031/12/200531/12/200614/02/200616/02/200612/04/2007-
08 Feb 2007FinalGBX-31/12/200531/12/2006---48.00
26 Oct 2006QuarterlyGBX12.0031/12/200531/12/200601/11/200603/11/200604/01/2007-
26 Jul 2006QuarterlyGBX11.0031/12/200531/12/200602/08/200604/08/200605/10/2006-
27 Apr 2006QuarterlyGBX11.0031/12/200531/12/200610/05/200612/05/200606/07/2006-
08 Feb 2006FinalGBX14.0031/12/200431/12/200515/02/200617/02/200606/04/200644.00
27 Oct 2005QuarterlyGBX10.0031/12/200431/12/200502/11/200504/11/200505/01/2006-
29 Jul 2005QuarterlyGBX10.0031/12/200431/12/200503/08/200505/08/200506/10/2005-
28 Apr 2005QuarterlyGBX10.0031/12/200431/12/200511/05/200513/05/200507/07/2005-
10 Feb 2005FinalGBX12.0031/12/200331/12/200416/02/200518/02/200507/04/200542.00
28 Oct 2004QuarterlyGBX10.0031/12/200331/12/200403/11/200405/11/200406/01/2005-
27 Jul 2004QuarterlyGBX10.0031/12/200331/12/200412/05/200414/05/200401/07/2004-
27 Jul 2004QuarterlyGBX10.0031/12/200331/12/200404/08/200406/08/200430/09/2004-
12 Feb 2004FinalGBX14.0031/12/200231/12/200318/02/200420/02/200415/04/200441.00
11 Feb 2004QuarterlyGBX9.0031/12/200231/12/200329/10/200331/10/200306/01/2004-
23 Jul 2003QuarterlyGBX9.0031/12/200231/12/200330/07/200301/08/200302/10/2003-
30 Apr 2003QuarterlyGBX9.0031/12/200231/12/200307/05/200309/05/200303/07/2003-
12 Feb 2003FinalGBX13.0031/12/200131/12/200219/02/200321/02/200317/04/200340.00
23 Oct 2002QuarterlyGBX9.0030/03/200230/09/200230/10/200201/11/200203/01/2003-
24 Jul 2002QuarterlyGBX9.0030/12/200130/06/200231/07/200202/08/200203/10/2002-
25 Apr 2002QuarterlyGBX9.0001/10/200131/03/200201/05/200203/05/200204/07/2002-
14 Feb 2002FinalGBX12.0031/12/200031/12/200120/02/200222/02/200218/04/200239.00
23 Oct 2001QuarterlyGBX9.0030/09/200030/09/200131/10/200102/11/200103/01/2002-
24 Jul 2001QuarterlyGBX9.0030/06/200030/06/200101/08/200103/08/200104/10/2001-
24 Apr 2001QuarterlyGBX9.0031/03/200031/03/200102/05/200104/05/200105/07/2001-
13 Dec 2000FinalGBX23.0031/12/199931/12/200018/12/200022/12/200017/04/200138.00
27 Jul 2000InterimGBX15.0030/12/199930/06/200007/08/200011/08/200016/10/2000-
16 Feb 2000FinalGBX22.0031/12/199831/12/199928/02/200003/03/200025/05/200037.00
29 Jul 1999InterimGBX15.0030/12/199830/06/199909/08/199913/08/199901/10/1999-
18 Feb 1999FinalGBX21.0031/12/199731/12/199801/03/199905/03/199920/05/199936.00

Gsk Fundamentals

Profit and Loss Account
 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
turnover30,821.00100.00%33,754.00100.00%34,099.00100.00%34,114.00100.00%m
pre tax profit4,048.0013.13%6,221.0018.43%6,968.0020.43%5,442.0015.95%m
attributable profit3,623.0011.75%4,645.0013.76%5,749.0016.86%4,385.0012.85%m
retained profit-304.00-0.99%692.002.05%1,772.005.20%386.001.13%m
eps - basic (p)73.70 93.90 115.50 87.60 
eps - diluted (p)72.90 93.90 114.10 86.60 
dividends per share80.00 80.00 80.00 80.00 

Gsk Balance Sheet

Balance Sheet
 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
L^GSK:Liabilities+EQL^GSK:AssetsL^GSK:Liabilities+EQL^GSK:AssetsL^GSK:Liabilities+EQL^GSK:AssetsL^GSK:Liabilities+EQL^GSK:Assets
 31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
ASSETS
fixed assets fixed assets11,058.0019.04%10,348.0012.98%11,006.0013.68%10,672.0013.49%m
intangibles intangibles22,991.0039.59%42,483.0053.31%40,421.0050.26%40,631.0051.36%m
fixed investments fixed investments3,475.005.98%3,774.004.74%4,700.005.84%4,157.005.26%m
current assets - other current assets - other653.001.12%873.001.10%106.000.13%22.000.03%m
stocks stocks5,476.009.43%5,947.007.46%5,996.007.45%5,783.007.31%m
debtors debtors10,539.0018.15%11,560.0014.51%11,910.0014.81%13,564.0017.15%m
cash & securities cash & securities3,874.006.67%4,707.005.91%6,292.007.82%4,274.005.40%m
TOTAL58,066.00100%79,692.00100%80,431.00100%79,103.00100%m
LIABILITIES
creditors - short creditors - short22,491.0038.73%24,050.0030.18%22,148.0027.54%23,670.0029.92%m
creditors - long creditors - long31,903.0054.94%37,285.0046.79%37,475.0046.59%34,091.0043.10%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL54,394.0093.68%61,335.0076.97%59,623.0074.13%57,761.0073.02%m
EQUITY
ord cap, reserves ord cap, reserves4,360.007.51%11,984.0015.04%14,587.0018.14%15,055.0019.03%m
prefs, minorities prefs, minorities-688.00-1.18%6,373.008.00%6,221.007.73%6,287.007.95%m
TOTAL3,672.006.32%18,357.0023.03%20,808.0025.87%21,342.0026.98%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Gsk Cash Flow Statement

%1$s Cash Flow Statement
31 Dec 2018 (GBP)31 Dec 2019 (GBP)31 Dec 2020 (GBP)31 Dec 2021 (GBP)
Operating CF8,421.008,020.008,441.007,952.00m
Pre-Financing CF6,868.002,666.0010,602.006,175.00m
Retained CF479.00826.00470.00-1,414.00m

Gsk Brokers

%1$s Brokers
NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
Your Recent History
LSE
GSK
Gsk
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:au D:20220818 01:46:48